No abstract available
MeSH terms
-
Antibodies, Monoclonal / administration & dosage*
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents / administration & dosage*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
CTLA-4 Antigen / antagonists & inhibitors*
-
Female
-
Humans
-
Ipilimumab
-
Male
-
Melanoma / drug therapy*
-
Nivolumab
-
Programmed Cell Death 1 Receptor / antagonists & inhibitors*
-
Skin Neoplasms / drug therapy*
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
CTLA-4 Antigen
-
Ipilimumab
-
PDCD1 protein, human
-
Programmed Cell Death 1 Receptor
-
Nivolumab
-
pembrolizumab